Appeal No. 1995-4572 Application 08/035,443 Claim 1 is illustrative of the subject matter on appeal and reads as follows: 1. In a method of treating a subject for septic shock by parenteral administration of polymyxin B, the improvement comprising parenterally administering to the subject, a liposome composition containing liposomes having an outer layer of polyethylene glycol chains and said polymyxin B covalently attached to the distal ends of said chains. The references relied upon by the examiner are: Woodle et al. (Woodle) 5,013,556 May 7, 1991 Hawrot et al. (Hawrot) 4,948,590 Aug. 14, 1990 Davis et al. (Davis) 4,179,337 Dec. 18, 1979 Eur. Pat. App. (Handley) 0 428 486 May 22, 1991 Claims 1, 2, 5 and 6 stand rejected under 35 U.S.C. § 103. The examiner first relies upon Woodle, Davis and Hawrot as evidence of obviousness. The examiner also relies upon Woodle, Davis, Hawrot and Handley as evidence of obviousness. We reverse both rejections. In addition, we raise other issues for consideration by the examiner. DISCUSSION It is first noted that both rejections rely upon the same references to Woodle, Hawrot and Davis. The second rejection relies upon the additional reference to Handley. All four of the references have been considered by this merits panel, and it is 2Page: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007